Following the patent expiry of semaglutide in India, leading pharma companies including Sun Pharma, Dr Reddy’s, Zydus, and ...

Torrent Pharmaceuticals has launched India's first generic oral semaglutide, alongside an injectable version, offering new ...

Torrent Pharma launches India's first oral semaglutide, offering injectable options at ₹3,999/month for diabetes and obesity treatment.

Sun Pharma to Dr Reddy's and Lupin are gearing up to launch over 50 brands that will compete with Ozempic, Wegovy and Mounjaro at half the price.

Glenmark Pharmaceuticals has announced the launch of GLIPIQ (semaglutide) in India for the management of Type 2 Diabetes Mellitus (T2DM), positioning it as a more affordable GLP-1 therapy aimed at ...

Natco Pharma said the multi-dose vial format is priced around 70% lower than pen devices and nearly 90% cheaper than the innovator product, aimed at improving patient access and long-term treatment ...

Ahmedabad: A clutch of Gujarat-based drugmakers has launched lower-cost versions of semaglutide following the molecule's patent expiry in India, intensifying competition in the fast-growing diabetes ...

Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news ...

The ongoing conflict in Iran, unfolding thousands of kilometres away, is now impacting the availability of essential ...

Medicine prices in India may rise 10–20% by March-end as Strait of Hormuz disruptions push up fuel, logistics and pharma manufacturing costs.

Built on a pharmaceutical legacy spanning over four decades, SKINLUV has emerged as a dedicated platform for ...

Sun Pharmaceutical Industries has announced the launch of its semaglutide injection in India under the brand names Noveltreat and Sematrinity, across multiple strengths for the treatment of obesity ...